Impact of risk of generalizability biases in adult obesity interventions: A meta-epidemiological review and meta-analysis
- PMID: 34779122
- PMCID: PMC8755584
- DOI: 10.1111/obr.13369
Impact of risk of generalizability biases in adult obesity interventions: A meta-epidemiological review and meta-analysis
Abstract
Biases introduced in early-stage studies can lead to inflated early discoveries. The risk of generalizability biases (RGBs) identifies key features of feasibility studies that, when present, lead to reduced impact in a larger trial. This meta-study examined the influence of RGBs in adult obesity interventions. Behavioral interventions with a published feasibility study and a larger scale trial of the same intervention (e.g., pairs) were identified. Each pair was coded for the presence of RGBs. Quantitative outcomes were extracted. Multilevel meta-regression models were used to examine the impact of RGBs on the difference in the effect size (ES, standardized mean difference) from pilot to larger scale trial. A total of 114 pairs, representing 230 studies, were identified. Overall, 75% of the pairs had at least one RGB present. The four most prevalent RGBs were duration (33%), delivery agent (30%), implementation support (23%), and target audience (22%) bias. The largest reductions in the ES were observed in pairs where an RGB was present in the pilot and removed in the larger scale trial (average reduction ES -0.41, range -1.06 to 0.01), compared with pairs without an RGB (average reduction ES -0.15, range -0.18 to -0.14). Eliminating RGBs during early-stage testing may result in improved evidence.
Keywords: intervention; pilot; scaling; translation.
© 2021 The Authors. Obesity Reviews published by John Wiley & Sons Ltd on behalf of World Obesity Federation.
Conflict of interest statement
No conflict of interest statement.
Figures





References
-
- National Institutes of Health , National Institute of Diabetes and Digestive and Kidney Diseases . Small R01s for clinical trials targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required). National Institutes of Health. https://grants.nih.gov/grants/guide/pa-files/pas-20-160.html. Published 2020. Accessed April 1st, 2021.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical